25.62
price down icon2.33%   -0.61
after-market After Hours: 25.68 0.06 +0.23%
loading
Cg Oncology Inc stock is traded at $25.62, with a volume of 726.92K. It is down -2.33% in the last 24 hours and down -4.90% over the past month. CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
See More
Previous Close:
$26.23
Open:
$25.85
24h Volume:
726.92K
Relative Volume:
0.56
Market Cap:
$1.95B
Revenue:
-
Net Income/Loss:
$-64.16M
P/E Ratio:
-20.17
EPS:
-1.2702
Net Cash Flow:
$-69.06M
1W Performance:
+0.71%
1M Performance:
-4.90%
6M Performance:
-26.27%
1Y Performance:
-25.28%
1-Day Range:
Value
$24.95
$26.10
1-Week Range:
Value
$24.79
$26.60
52-Week Range:
Value
$14.80
$40.47

Cg Oncology Inc Stock (CGON) Company Profile

Name
Name
Cg Oncology Inc
Name
Phone
(949) 419-6203
Name
Address
400 SPECTRUM CENTER DRIVE, IRVINE
Name
Employee
113
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CGON's Discussions on Twitter

Compare CGON with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CGON
Cg Oncology Inc
25.62 1.94B 0 -64.16M -69.06M -1.2702
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Cg Oncology Inc Stock (CGON) Upgrades & Downgrades

Date Action Analyst Rating Change
May-02-25 Initiated JP Morgan Overweight
Apr-16-25 Initiated Scotiabank Sector Perform
Jan-07-25 Initiated TD Cowen Buy
Oct-24-24 Initiated UBS Buy
Sep-23-24 Initiated RBC Capital Mkts Outperform
Aug-28-24 Initiated ROTH MKM Buy
Jun-28-24 Initiated BofA Securities Buy
Feb-20-24 Initiated Cantor Fitzgerald Overweight
Feb-20-24 Initiated Goldman Neutral
Feb-20-24 Initiated Morgan Stanley Overweight
Feb-14-24 Initiated H.C. Wainwright Buy
View All

Cg Oncology Inc Stock (CGON) Latest News

pulisher
May 31, 2025

BNP Paribas Financial Markets Lowers Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 31, 2025
pulisher
May 29, 2025

CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

May 29, 2025
pulisher
May 27, 2025

CG Oncology’s SWOT analysis: bladder cancer treatment stock shows promise amid competition - Investing.com

May 27, 2025
pulisher
May 27, 2025

Bank of America Corp DE Has $6.01 Million Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 27, 2025
pulisher
May 27, 2025

Millennium Management LLC Invests $7.14 Million in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 27, 2025
pulisher
May 27, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,026 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 27, 2025
pulisher
May 26, 2025

CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success - MSN

May 26, 2025
pulisher
May 26, 2025

Deutsche Bank AG Acquires 13,589 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 26, 2025
pulisher
May 20, 2025

CG Oncology (NASDAQ:CGON) Given New $52.00 Price Target at Morgan Stanley - Defense World

May 20, 2025
pulisher
May 19, 2025

CGON Stock Rating Maintained by Morgan Stanley Despite Price Target Cut | CGON Stock News - GuruFocus

May 19, 2025
pulisher
May 18, 2025

Cantor Fitzgerald Lowers Earnings Estimates for CG Oncology - Defense World

May 18, 2025
pulisher
May 17, 2025

CG Oncology, Inc. (NASDAQ:CGON) Position Boosted by Northern Trust Corp - Defense World

May 17, 2025
pulisher
May 16, 2025

Q2 Earnings Forecast for CG Oncology Issued By HC Wainwright - Defense World

May 16, 2025
pulisher
May 15, 2025

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Leading Bladder Cancer Drug Developer CG Oncology Takes Stage at Major RBC Healthcare Conference - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Analysts Are Bullish on These NA Stocks: American Healthcare REIT, Inc. (AHR), CG Oncology, Inc. (CGON) - The Globe and Mail

May 15, 2025
pulisher
May 14, 2025

CG Oncology (NASDAQ:CGON) Shares Gap Down on Disappointing Earnings - Defense World

May 14, 2025
pulisher
May 14, 2025

Decoding CG Oncology Inc (CGON): A Strategic SWOT Insight - GuruFocus

May 14, 2025
pulisher
May 13, 2025

CG Oncology reports Q1 EPS (45c), consensus (37c) - TipRanks

May 13, 2025
pulisher
May 13, 2025

CGON Q1 Revenue Falls Short; Advances in Bladder Cancer Therapy - GuruFocus

May 13, 2025
pulisher
May 13, 2025

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates - ADVFN

May 13, 2025
pulisher
May 13, 2025

CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

CG Oncology Q1 Loss Widens, Revenue Falls - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

CG Oncology, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025
pulisher
May 06, 2025

Here Are Reasons Why Cg Oncology Inc (NASDAQ: CGON) Is A Great Choice Now - Stocksregister

May 06, 2025
pulisher
May 05, 2025

CG Oncology Jumps 25% on Positive Trial Results - Orange County Business Journal

May 05, 2025
pulisher
May 05, 2025

CG Oncology (NASDAQ:CGON) Earns Overweight Rating from Analysts at JPMorgan Chase & Co. - Defense World

May 05, 2025
pulisher
May 04, 2025

CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 04, 2025
pulisher
May 03, 2025

CG Oncology, Inc. (NASDAQ:CGON) Shares Purchased by Invesco Ltd. - Defense World

May 03, 2025
pulisher
May 02, 2025

CG Oncology initiated with an Overweight at JPMorgan - TipRanks

May 02, 2025
pulisher
May 02, 2025

CGON Stock: JP Morgan Initiates Coverage with Overweight Rating - GuruFocus

May 02, 2025
pulisher
May 02, 2025

JPMorgan Initiates Coverage on CG Oncology With Overweight Rating, $41 Price Target - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

CGON: JPMorgan Starts Coverage with Overweight Rating and $41 Ta - GuruFocus

May 02, 2025
pulisher
May 02, 2025

CG Oncology (NASDAQ:CGON) Reaches New 1-Year Low After Insider Selling - Defense World

May 02, 2025
pulisher
May 02, 2025

CGON: JPMorgan Starts Coverage with Overweight Rating and $41 Target | CGON Stock News - GuruFocus

May 02, 2025
pulisher
May 01, 2025

Why CG Oncology, Inc. (CGON) Surged on Monday - MSN

May 01, 2025
pulisher
May 01, 2025

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Cg Oncology Inc’s (CGON) Stock Is Harder To Predict Than You Think - Stocksregister

May 01, 2025
pulisher
May 01, 2025

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award - The Manila Times

May 01, 2025
pulisher
May 01, 2025

CG Oncology, Inc. (NASDAQ:CGON) Shares Bought by Wells Fargo & Company MN - Defense World

May 01, 2025
pulisher
Apr 30, 2025

A look into Cg Oncology Inc (CGON)’s deeper side - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Stock Performance Spotlight: Cg Oncology Inc (CGON) Ends the Day at 26.94, Down by -3.68 - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Could Cg Oncology Inc (NASDAQ: CGON) Be The Biggest Winner? - Marketing Sentinel

Apr 30, 2025
pulisher
Apr 30, 2025

Barclays PLC Acquires 10,737 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

CG Oncology's Bladder Cancer Drug Impresses InvestorsHere's Why - AOL.com

Apr 29, 2025
pulisher
Apr 29, 2025

Cg Oncology Inc [CGON] Stock sold by Insider POST LEONARD E for $28000.0 - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains? - MSN

Apr 29, 2025
pulisher
Apr 29, 2025

TD Cowen Sticks to Its Buy Rating for CG Oncology, Inc. (CGON) - The Globe and Mail

Apr 29, 2025
pulisher
Apr 29, 2025

CG Oncology (NASDAQ:CGON) Given Overweight Rating at Cantor Fitzgerald - Defense World

Apr 29, 2025
pulisher
Apr 29, 2025

CG Oncology’s (CGON) Buy Rating Reaffirmed at HC Wainwright - Defense World

Apr 29, 2025

Cg Oncology Inc Stock (CGON) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Cg Oncology Inc Stock (CGON) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
POST LEONARD E
Director
May 21 '25
Sale
28.00
1,000
28,000
0
POST LEONARD E
Director
Apr 28 '25
Option Exercise
0.60
1,000
600
1,000
POST LEONARD E
Director
Apr 28 '25
Sale
30.76
1,000
30,760
0
POST LEONARD E
Director
Mar 17 '25
Option Exercise
0.60
1,000
600
1,000
POST LEONARD E
Director
Mar 17 '25
Sale
28.00
1,000
28,000
0
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Cap:     |  Volume (24h):